Accessibility Menu
 

American Oncology Network

(OTC) AONC

Current Price$11.50
Market Cap$336.84M
Since IPO (2021)+20%
5 YearN/A
1 Year+120%
1 Month+0%

American Oncology Network Financials at a Glance

Market Cap

$336.84M

Revenue (TTM)

$1.76B

Net Income (TTM)

$3.97M

EPS (TTM)

$-1.38

P/E Ratio

-8.36

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$11.50

Volume

100

Open

$11.50

Previous Close

$11.50

Daily Range

$11.50 - $11.50

52-Week Range

$0.00 - $14.25

AONC News

No articles available.

AONC: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About American Oncology Network

Industry

Healthcare Providers and Services

Employees

1,914

CEO

Todd Schonherz

Headquarters

Fort Myers, FL 33913, US

AONC Financials

Key Financial Metrics (TTM)

Gross Margin

8%

Operating Margin

1%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

4%

Return on Assets

0%

Earnings Yield

-11.96%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$336.84M

Shares Outstanding

29.29M

Volume

100

Short Interest

0.00%

Avg. Volume

65.683

Financials (TTM)

Gross Profit

$117.85M

Operating Income

$17.43M

EBITDA

$1.81M

Operating Cash Flow

$4.94M

Capital Expenditure

$20.95M

Free Cash Flow

$25.90M

Cash & ST Invst.

$72.64M

Total Debt

$147.37M

American Oncology Network Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2024YOY CHG

Revenue

$490.88M

+51.4%

Gross Profit

$42.53M

+393.4%

Gross Margin

8.66%

N/A

Market Cap

$336.84M

N/A

Market Cap/Employee

$175.99K

N/A

Employees

1,914

N/A

Net Income

$1.32M

+135.1%

EBITDA

$9.44M

+158.3%

Quarterly Fundamentals

Name
Q4 2024YOY CHG

Net Cash

$74.73M

-16.0%

Accounts Receivable

$189.63M

+14.9%

Inventory

$60.71M

+36.2%

Long Term Debt

$135.14M

+8.1%

Short Term Debt

$12.23M

-22.4%

Return on Assets

0.05%

N/A

Return on Invested Capital

3.87%

N/A

Free Cash Flow

$5.60M

+138.1%

Operating Cash Flow

$11.93M

+199.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SLNCFSilence Therapeutics plc
$2.00+0.00%
HNSBFHansa Biopharma AB (publ)
$2.90+0.00%
BHCCFBenchmark Holdings plc
$0.37+0.00%
MFCSFMedical Facilities Corporation
$12.06-1.95%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.62-0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.61+0.00%
ONDSOndas
$10.68-0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.00+0.01%

Questions About AONC

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.